Interleukin-13 , polymorphisms

Garcia-Montero AC, Jara-Acevedo M. Teodosio C. et al KIT mutation in mast cells and other bone marrow hematopoietic cell hneages in systemic mast cell disorders a prospective study of the Spanish Network on Mastocytosis (REMA) in a series of 113 patients. Blood 2006 108 2366-2372. Daley T, Metcalfe DD, Akin C Association of the Q576R polymorphism in the interleukin-4 receptor a chain with indolent mastocytosis limited to the skin. Blood 2001 98 880-882. [Pg.123]

Stemmier S, Arinir U, Klein W, et al. Association of interleukin-8 receptor alpha polymorphisms with chronic obstructive pulmonary disease and asthma. Genes Immun 2005 6(3) 225-230. [Pg.256]

Given the role of H. pylori infection in gastric cancer and duodenal ulcer disease, one must note that certain interleukin-1 gene cluster polymorphisms (suspected of increasing production of interleukin-1-/1) are associated with a predisposition to hypochlorhydria and gastric cancer [52]. One of these host DNA polymorphisms involves a TATA box. [Pg.22]

El-Omar EM et al. Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 2000 404J6776] 398—402. [Pg.34]

Yee LJ, Tang J, Gibson AW, Kimberly R, Van Leeuwen DJ, Kaslow RA. Interleukin 10 polymorphisms as predictors of sustained response in antiviral therapy for chronic hepatitis C infection. Hepatology 2001 33[3] 708—712. [Pg.80]

Vidigal, P. G., Germer, J. J., and Zein, N. N., Polymorphisms in the interleukin-10, tumor necrosis factor-alpha, and transforming growth factor-betal genes in chronic hepatitis C patients treated with interferon and ribavirin, J. Hepatol., 36, 271, 2002. [Pg.93]

Yucesoy, B. et al., Association of tumor necrosis factor-alpha and interleukin-1 gene polymorphisms with silicosis, Toxicol. Appl. Pharmacol., 172, 75, 2001. [Pg.93]

Takamatsu, M. et al., Genetic polymorphisms of interleukin-1 beta in association with the development of alcoholic liver disease in Japanese patients, Am. J. Gastroenterol., 95 (5), 1305, 2000. [Pg.95]

Kastrati A, Koch W, Berger PB, et al. Protective role against restenosis from an interleukin-1 receptor antagonist gene polymorphism in patients treated with coronary stenting. J Am Coll Cardiol 2000 36 2168-2173. [Pg.206]

ETN, etanercept IL, interleukin INF, infliximab MHC, major histocompatibility complex PBMC, peripheral blood mononuclear cell SNP, single-nucleotide polymorphism. [Pg.430]

NT302 Meisel, P., C. Schwahn, D. Gesch, O. N P312 Bernhardt, U. John, and T. Kocher. Dose-dependent relation of smoking and the interleukin-1 gene polymorphism in periodontal tissue. J Perio-dontol 2004 75(2) 236-242. [Pg.356]

Fishman D, Faulds G, Jeffery R, Mohamed-Ali V, Yudkin JS, Humphries S, Woo P. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest 1998 102 1369-1376. [Pg.208]

Capurso C, Solfrizzi V, D lntrono A, Colacicco AM, Capurso SA, Semeraro C, Capurso A, Panza F. Interleukin 6-174 G/C promoter gene polymorphism in centenarians No evidence of association with human longevity or interaction with apolipoprotein E alleles. Exp Gerontol 2004 39 1109-1114. [Pg.209]

Burzotta F, Iacoviello L, Di Castelnuovo A, et al. Relation of the-174 G/C polymorphism of interleukin-6 to interleukin-6 plasma levels and to length of hospitalization after surgical coronary revascularization. Am J Cardiol 2001 88 1125-1128. [Pg.209]

Pola R, Flex A, Gaetani E, Lago AD, Gerardino L, Pola P, Bernabei R. The-174 G/C polymorphism of the interleukin-6 gene promoter is associated with Alzheimer s disease in an Italian population. Neuroreport 2002 13 1645-1647. [Pg.209]

Pola R, Gaetani E, Flex A, Aloi F, Papaleo P, Gerardino L, De Martini D, Flore R, Pola P, Bernabei R. -174 G/C interleukin-6 gene polymorphism and increased risk of multiinfarct dementia A case-control study. Exp Gerontol 2002 37 949-955. [Pg.209]

Rauramaa R, Vaisanen SB, Luong LA, Schmidt-Trucksass A, Penttila IM, Bouchard C, Toyry J, Humphries SE. Stromelysin-1 and interleukin-6 gene promoter polymorphisms are determinants of asymptomatic carotid artery atherosclerosis. Arterioscler Thromb Vase Biol 2000 20 2657-2662. [Pg.209]

Rea IM, Ross OA, Armstrong M, McNerlan S, Alexander DH, Curran MD, Middleton D. Interleukin-6-gene C/G 174 polymorphism in nonagenarian and octogenarian subjects in the BELFAST study. Reciprocal effects on IL-6, soluble IL-6 receptor and for IL-10 in serum and monocyte supernatants. Mech Agein Dev 2003 124 555-561. [Pg.209]

Chen H, Wilkins LM, Aziz N, Cannings C, Wyllie DH, Bingle C et al. Single nucleotide polymorphisms in the human interleukin-IB gene affect transcription according to haplotype context. Hum Mol Genet 2006, 15(4) 519-529. [Pg.195]

Iacoviello L, Di Castelnuovo A, Gattone M, Pezzini A, Assanelli D, Lorenzet R et al. Polymorphisms of the interleukin-lbeta gene affect the risk of myocardial infarction and ischemic stroke at young age and the response of mononuclear cells to stimulation in vitro. Arterioscler Thromb Vase Biol 2005, 25(l) 222-227. [Pg.195]

Hobbs, K., Negri, J., Klinnert, M., Rosenwasser, L. J., and Borish, L. 1998. Interleukin-10 transforming growth factor-beta promoter polymorphisms in allergies and asthma. Am J Respir Crit Care Med 158 1958-1962. [Pg.37]

Nishimura M, Mizuta I, Mizuta E, Yamasaki S, Ohta M, Kuno S (2000) Influence of interleukin-lbeta gene polymorphisms on age-at-onset of sporadic Parkinson s disease. Neurosci Lett 284 73-76. [Pg.658]

Lin M-T, Storer B, Martin PJ, et al. Relation of an interleukin-10 promoter polymorphism to graft-versus-host disease and survival after hematopoietic-cell transplantation. N Engl J Med 2003 349 2201-10. [Pg.734]

Multigene studies have shown that interleukin (IL)-1 3 genetic polymorphism, although not an independent factor in treatment outcome, influences the impact of the CYP2C19 genotype on the cure rate of 1-week triple therapy for H. pylori infections. ... [Pg.1601]

Schotte H, Schluter B, Drynda S, Willeke P, Tidow N, Assmann G et al (2005) Interleukin 10 promoter microsatellite polymorphisms are associated with response to long term treatment with etanercept in patients with rheumatoid arthritis. Ann Rheum Dis 64 575-581... [Pg.659]

Jancic I, Arsenovic-Ranin N, Sefik-Bukilica M, Zivojinovic S, Damjanov N, Spasovski V et al (2013) 174G/C interleukin-6 gene promoter polymorphism predicts therapeutic response to etanercept in rheumatoid arthritis. Rheumatol Int 33 1481-1486... [Pg.659]

Walley AJ, Cookson WOCM Investigatiorr of an interleukin-4 promoter polymorphism for associations with asthma and atopy. J Med Genet 1996 33 689-692. (Ill)... [Pg.31]

KawashimaT, Noguchi E, Arinami T. et al Linkage and association of an interleukin 4 gene polymorphism with atopic dermatitis in Japanese families. J Med Genet 1998 35 502-504. (Ill)... [Pg.32]

Pantelidis P, Jones MG, Welsh KI, et al Identification of four novel interleukin-13 gene polymorphisms. Genes Immun 2000 1 341-345. (NC)... [Pg.32]

Howard TD, Whittaker PA, Zaiman AL, et al Identification and association of polymorphisms in the interleukin-13 gene with asthma and atopy in a Dutch population. Am J Respir Cell Mol Biol 2001 25 377-384. (Ill)... [Pg.32]

Cantagrel A, Navaux F, Loubet-Lescoulie P, Nourhashemi F, Enault G, Abbal M, Constantin A, Laroche M, Mazieres B (1999) lnterleukin-1 p, interieukin-1 receptor antagonist, interleukin-4, and interieukin-10 gene polymorphisms. Relationship to occurrence and severity of rheumatoid arthritis. Arthritis Rheum, 42 1093-1100. [Pg.265]

McDowell TL, Symons JA, Ploski R, Forre O, Duff GW (1995) A genetic association between juvenile rheumatoid arthritis and a novel interleukin-1a polymorphism. Arthritis Rheum, 38 221-228. [Pg.294]

Parks CG, Pandey JP, Dooley MA, Treadwell EL, St Clair EW, Gilkeson GS, Feghali-Bostwick CA, Cooper GS (2004b) Genetic polymorphism in tumor necrosis factor (TNF)-alpha and TNF-beta in a population-based study of systemic lupus erythematosus associations and interaction with the interleukin-1 alpha-889 C/T polymorphism. Hum Immunol, 65 622-631. [Pg.300]

Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...